Results 131 to 140 of about 18,607 (256)

Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe

The Lancet Regional Health. Europe, 2022
Maurizio Scarpa, James R. Bonham, Carlo Dionisi-Vici, Johan Prevot, Martine Pergent, Isabelle Meyts, Nizar Mahlaoui, Peter C.J.I. Schielen   +7 more
doaj   +1 more source

ICF syndrome: An epigenetic paradigm for primary immunodeficiencies. [PDF]

J Hum Immun
Martins-Ferreira R, Ballestar E.
europepmc   +1 more source

Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation

Biopharmaceutics &Drug Disposition, EarlyView.
Pharmacokinetic interactions between Echinacea and two antiviral drugs, favipiravir and atazanavir, were assessed in rats. The findings suggest that Echinacea does not significantly affect the pharmacokinetics of favipiravir and atazanavir. These results provide preliminary evidence that concurrent use of Echinacea with these antiviral drugs may be ...
Siva Nageswara Rao Gajula, Jeevan Sai Kallam, Aarika Kanukolanu, Ganesh Korada, Lakshmi Vineela Nalla   +4 more
wiley   +1 more source

MAURIVAX: A Vaccination Campaign Project in a Hospital Environment for Patients Affected by Autoimmune Diseases and Adult Primary Immunodeficiencies. [PDF]

Vaccines (Basel), 2023
Ridolfi I, Lo Sardo L, Nicola S, Borrelli R, Comola L, Marmora V, Badiu I, Corradi F, Azzolina MCR, Brussino L.   +9 more
europepmc   +1 more source

Fouling‐Free Inertial Microfluidic Cell Clarification for Lentivirus Manufacturing

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Lentiviral vectors (LVVs) are widely used as gene‐delivery vehicles in cell and gene therapy, enabling stable integration of transgenes into target cells. However, efficient clarification of LVV harvest remains a major bottleneck in large‐scale manufacturing, as conventional depth filtration often results in significant product loss.
Dohyun Park, Alexander Bevacqua, Mingyang Cui, Marina Nichols, Jianzhu Chen, Jongyoon Han   +5 more
wiley   +1 more source

Progress in Diagnosis and Treatment of Primary Immunodeficiencies. [PDF]

J Clin Med
Grammatikos A.
europepmc   +1 more source

Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia

BMEMat, EarlyView.
CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai, Rui Zhang, Haiyin Yang, Jiyue Xing, Tianyuan Hu, Mengxi Zhu, Rui Li, Xiaoli Chen, Beibei Zhao, Yang Lan, Stefan Barth, Yuanyu Huang, Li Zhang, Mengjie Zhang, Huining He   +14 more
wiley   +1 more source

IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot Study. [PDF]

J Clin Immunol
Collet A, Coiffard B, Ledoult E, Fieschi C, Cheminant M, Serris A, Suarez F, Sanges S, Neel A, Nove-Josserand R, Stabler S, El Husseini K, Huault A, Cougoul P, Mausservey C, Cassir N, Mirgot F, Meresse B, Dendooven A, Poizot S, Le Scornet T, Bravard AS, Conrad A, Levêque M, Fadlallah J, Melenotte C, De La Roque CD, Tinevez C, Chahla WA, Dubucquoi S, Labalette M, Neven B, Malphettes M, Schleinitz N, Galicier L, Viallard JF, Gorochov G, Lefèvre G.   +37 more
europepmc   +1 more source

Editorial: Advances in primary immunodeficiencies (inborn errors of immunity) in Central-Eastern Europe, volume II. [PDF]

Front Immunol, 2023
Pac M, Casanova JL, Tuzankina I, Maródi L.   +3 more
europepmc   +1 more source

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

BMEMat, EarlyView.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu, Xuetian Wen, Yue Tan, Rui Zeng, Yijuan Zhang, Tong Lin, Lan Gong, Zichao Luo   +7 more
wiley   +1 more source